Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia
NCT00005618
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
Leukemia
Interventions
DRUG:
arsenic trioxide
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
[object Object]